Evidence map›Paper›PMID 39391100›Full record

ArticleOpen forum infectious diseases2024

Association of Race or Ethnicity With Extended-Spectrum Beta-Lactamase Production in

Alice N Hemenway, Mark Biagi, Timothy F Murrey, Jiehuan Sun, Erica Osei-Badu, Adriana Salazar-McKinney, Ricardo Sanabria, Moamen Al Zoubi

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Spatial pattern and risk factors of resistance to important antibiotics amongAntimicrobial stewardship & healthcare epidemiology : ASHE · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alice N HemenwayDepartment of Pharmacy Practice, University of Illinois Chicago College of Pharmacy- Rockford Health Sciences Campus, Rockford, Illinois, USA.ORCID https://orcid.org/0000-0002-2363-4431
Mark BiagiDepartment of Pharmacy Practice, University of Illinois Chicago College of Pharmacy- Rockford Health Sciences Campus, Rockford, Illinois, USA.ORCID https://orcid.org/0000-0001-5190-0066
Timothy F MurreyDepartment of Pharmacy, OSF Saint Anthony Medical Center, Rockford, Illinois, USA.
Jiehuan SunDivision of Epidemiology and Biostatistics, School of Public Health, University of Illinois Chicago, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0002-5940-4822
Erica Osei-BaduUniversity of Illinois Chicago College of Pharmacy- Rockford Health Sciences Campus, Rockford, Illinois, USA.
Adriana Salazar-McKinneyUniversity of Illinois Chicago College of Pharmacy- Rockford Health Sciences Campus, Rockford, Illinois, USA.
Ricardo SanabriaUniversity of Illinois Chicago College of Pharmacy- Rockford Health Sciences Campus, Rockford, Illinois, USA.
Moamen Al ZoubiDepartment of Infectious Disease, Mercyhealth, Rockford, Illinois, USA.ORCID https://orcid.org/0000-0002-7471-5522

Funding

Strengthening Stakeholder Engagement in Human Research Protections.UL1TR002003 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARNIK, NIRANJAN SUBHASH, MERMELSTEIN, ROBIN J. · 2016 to 2024
$33.7M
NCATS NIH HHS UL1 TR002003
6 · The paper itself

Abstract

Background: There are limited and conflicting data regarding the impact of race or ethnicity on the rate of gram-negative antimicrobial resistance. This study was performed to determine whether there is a difference in extended-spectrum beta-lactamase (ESBL) Methods: A case control study was performed, with controls with non-ESBL Results: A total of 364 matched pairs were included in the analysis. Females were the majority of the sample (91%), with median age of 65 years. The majority of the sample identified as White (73%), followed by Hispanic (14%) and Black (10%). Urine cultures made up the majority of the cultures in the sample (97%), and this was similar between ESBL and non-ESBL groups. While controlling for these risk factors for ESBL Conclusions: In our sample, which is demographically similar to the United States, minoritized patients had higher odds of ESBL-producing

Indexed as

case-control studyextended-spectrum beta-lactamasegram-negative resistancehealth disparityhealth equity

Identifiers

PMID39391100
PMCPMC11465405

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.